Archive | 2021

Effect of Fuke Qianjin Tablets combined with fosfomycin tromethamine in treating patients with chronic pelvic inflammatory disease

 

Abstract


Objective \xa0To explore the effect of Fuke Qianjin Tablets combined with fosfomycin tromethamine in treating patients with chronic pelvic inflammatory disease and its influence on inflammatory factors and quality of sexual life. Methods \xa0A total of 86 chronic pelvic inflammatory disease patients were selected as research objects, and were randomly divided into control group and combined group, with 43 cases in each group. The control group was orally treated with fosfomycin tromethamine powder, and the combined group was given Fuke Qianjin Tablets on the basis of the control group. The treatment of both groups lasted 12 weeks. The therapeutic effects of the two groups were compared, interleukin-1β (IL-1β), interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α), female sexual function index (FSFI) scores and the incidences of adverse reactions of the two groups were compared between the two groups before and after treatment. Results \xa0The total effective rate in the combined group was significantly higher than that of the control group (P 0.05). Conclusion \xa0Fuke Qianjin Tablets combined with fosfomycin tromethamine has a significant effect on chronic pelvic inflammatory disease patients, which can regulate the level of inflammatory factors, and improve the quality of sexual life.

Volume 25
Pages None
DOI 10.7619/JCMP.20200496
Language English
Journal None

Full Text